drugset / Trial / NCT00002078
Phase I Study of Alferon N Injection in Persons With Asymptomatic Human Immunodeficiency Virus (HIV) Infection
Phase 1
Completed
Purdue Frederick
Henry M. Jackson Foundation for the Advancement of Military Medicine · collabWalter Reed Army Institute of Research (WRAIR) · collab
Treatment
Summary
To determine the safety and tolerance of subcutaneous injections of natural interferon alpha (IFN) in asymptomatic HIV-positive persons and record its effects on the HIV virus in these individuals.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Publications
- Background Skillman DR, Wagner K, Malone JL, Decker C, Paparello S, Meltzer MS. Phase 1 study of interferon alfa-N3 in asymptomatic HIV-infected persons. Int Conf AIDS. 1993 Jun 6-11;9(1):468 (abstract no PO-B26-1998)
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon alfa-n3 | Protein / enzyme biologic | — | Subcutaneous |